LY-510929, formerly known as LY-929, is a peroxisome proliferator-activated receptor (PPAR) agonist potentially for the treatment of hyperlipidaemia, metabolic disorders and type 2 diabetes. References: Engle SK, Solter PF, Credille KM, Bull CM, Adams S, Berna MJ, Schultze AE, Rothstein EC, Cockman MD, Pritt ML, Liu H, Lu Y, Chiang AY, Watson DE. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging. Toxicol Sci. 2010 Apr;114(2):183-92. doi: 10.1093/toxsci/kfp311. PubMed PMID: 20044590.

纯度：≥98%

CAS：401789-93-3